Viewing Study NCT04707703


Ignite Creation Date: 2025-12-24 @ 7:24 PM
Ignite Modification Date: 2025-12-28 @ 10:22 PM
Study NCT ID: NCT04707703
Status: TERMINATED
Last Update Posted: 2022-11-25
First Post: 2021-01-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Isavuconazole for the Prevention of COVID-19-associated Pulmonary Aspergillosis
Sponsor: Jeffrey Jenks, MD, MPH
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module